Gaurav Goyal

Gaurav Goyal practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Gaurav Goyal's NPI, 1346681772, was assigned on July 14, 2013. Gaurav Goyal holds Alabama license 37970.

Gaurav Goyal's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Gaurav Goyal's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Gaurav Goyal is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Gaurav Goyal practices. Vendor and product names are available with a free account.

Hematology and oncology is Gaurav Goyal's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Gaurav Goyal is licensed in Alabama.

CMS data shows 184 Medicare services from Gaurav Goyal across 4 procedure codes in 2024, for 53 Medicare patients. Medicare paid $11,512 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Gaurav Goyal in 2024. The largest group is 65 to 74, with 25 patients. 68% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gaurav Goyal's median patient age at 58, with 54% women.

In 2024, Gaurav Goyal wrote 129 Medicare Part D claims for 25 patients. 64% of them were for generic drugs. CMS names the drug for 38 of them, across 3 drugs with 11 or more claims each, at $201,029 in total drug cost. In 2023, CMS named 69 claims across 5 drugs.

Gaurav Goyal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 141 papers to Gaurav Goyal, published from 2011 to 2025. 2018 was the busiest year, with 13. The most frequent topics are Erdheim-Chester Disease, Histiocytosis, Langerhans-Cell and Antineoplastic Combined Chemotherapy Protocols. Gaurav Goyal has published most often in Br J Haematol. Gaurav Goyal's most frequent co-authors are Ronald S. Go, MD, Jithma Prasad Abeykoon, MD and Mithun Vinod Shah, MD, PhD.

Dmand AI links Gaurav Goyal to 6 clinical trials, 3 of them phase 1 studies. 4 are still active or recruiting. Conditions studied include Hodgkin Disease, Lymphoma, B-Cell, Marginal Zone and Lymphoma, Mantle-Cell. National Cancer Institute (NCI) sponsors the most, 4.

CMS Open Payments shows 51 general payments to Gaurav Goyal from 12 drug and device companies from 2019 to 2025. Honoraria make up the largest share, 43% of the total. Recordati_rare_diseases_inc. paid the most, $17,387.